Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-098439

Chief Legal Officer acquired 74,660 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mazzariello Gina · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 1 in the form +74,660 209,090 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 2 in the form Stock Option (Right to Buy) +111,990 111,990 D
Loading xslF345X05/ownership.xml…